Background The aim of this study was to analyse two groups of patients operated for bronchopulmonary neuroendocrine neoplasms (bronchial carcinoid and well-differentiated neuroendocrine carcinoma) and to investigate their clinico-pathological data and long-term survival. Methods. From January 1978 to June 1996, 65 patients with bronchial carcinoids underwent operation at our Institution. There were 33 males and 32 females, whose mean age was 49.8 years. Forty-four neoplasms (67.7%) were considered to be central. Histology revealed 54 typical bronchial carcinoids (83%) and 11 well-differentiated neuroendocrine carcinomas (17%), Surgical resection of tumor and complete lymph node dissection was performed in all cases, Results, All patients entered follow-up: 5-year survival was 91% for patients with bronchial carcinoid and 49% for those with well-differentiated neuroendocrine carcinoma (p<0.05). Univariate analysis found that there was a significant decrease in survival also for peripheral location of the tumor, advanced pathologic stage and histologically positive lymph nodes. Conclusions. These results point out that carcinoid tumors are malignant neoplasms, so they require a complete and radical surgical resection, Most tumors are only locally invasive and show a low aggressive behaviour; therefore, when possible, it is recommended to attempt a limited resection, Frozen sections of bronchial margins and complete lymphadenectomy should be routinely performed. The same criteria should apply to well differentiated neuroendoctine carcinomas, though their behaviour is more aggressive.
Carcinoid tumors of the lung: an analysis of 65 operated cases / Stefani, Alessandro; Morandi, Uliano; Urgese, Al; Rivasi, Francesco; Lodi, Renzo. - In: JOURNAL OF CARDIOVASCULAR SURGERY. - ISSN 0021-9509. - ELETTRONICO. - 40:(1999), pp. 607-612.
Carcinoid tumors of the lung: an analysis of 65 operated cases
STEFANI, Alessandro;MORANDI, Uliano;RIVASI, Francesco;LODI, Renzo
1999
Abstract
Background The aim of this study was to analyse two groups of patients operated for bronchopulmonary neuroendocrine neoplasms (bronchial carcinoid and well-differentiated neuroendocrine carcinoma) and to investigate their clinico-pathological data and long-term survival. Methods. From January 1978 to June 1996, 65 patients with bronchial carcinoids underwent operation at our Institution. There were 33 males and 32 females, whose mean age was 49.8 years. Forty-four neoplasms (67.7%) were considered to be central. Histology revealed 54 typical bronchial carcinoids (83%) and 11 well-differentiated neuroendocrine carcinomas (17%), Surgical resection of tumor and complete lymph node dissection was performed in all cases, Results, All patients entered follow-up: 5-year survival was 91% for patients with bronchial carcinoid and 49% for those with well-differentiated neuroendocrine carcinoma (p<0.05). Univariate analysis found that there was a significant decrease in survival also for peripheral location of the tumor, advanced pathologic stage and histologically positive lymph nodes. Conclusions. These results point out that carcinoid tumors are malignant neoplasms, so they require a complete and radical surgical resection, Most tumors are only locally invasive and show a low aggressive behaviour; therefore, when possible, it is recommended to attempt a limited resection, Frozen sections of bronchial margins and complete lymphadenectomy should be routinely performed. The same criteria should apply to well differentiated neuroendoctine carcinomas, though their behaviour is more aggressive.File | Dimensione | Formato | |
---|---|---|---|
Carcinoid tumors of the lung an analysis of 65 operated cases.pdf
Accesso riservato
Descrizione: articolo principale
Tipologia:
Versione pubblicata dall'editore
Dimensione
3.01 MB
Formato
Adobe PDF
|
3.01 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris